Particle.news

Download on the App Store

Paradromics implants dime-size Connexus brain-computer interface in first human test

Safe recording of individual neuron signals during epilepsy surgery positions the Connexus device for clinical trials in late 2025.

Image
Image
Paradromics completes first human BCI implant,

Overview

  • The Connexus implant was placed and removed in about 20 minutes during a May 14 University of Michigan epilepsy surgery, successfully capturing neural activity without adverse effects.
  • The fully implantable system uses 420 microelectrodes pushed into brain tissue and wirelessly transmits data to an under-the-skin transceiver.
  • Paradromics will seek regulatory approval to launch a clinical trial later this year to study the device’s long-term safety and efficacy in humans.
  • The company aims to decode neural signals into synthesized speech, text and cursor control to restore communication for patients with paralysis from ALS, stroke or spinal cord injury.
  • This milestone advances Paradromics into the clinical stage alongside competitors Neuralink, Synchron and Precision Neuroscience in the race to commercialize high-resolution BCIs.